This is consistent with studies on breast cancer cells and on mutant transgenic mice, showing that cytoplasmic SCRIB promotes cancer development by affecting subcellular localization of PTEN and activation of the Akt/mTOR/S6 kinase signaling pathway [44,48]. This evidence concerns the gene AKT1 and breast carcinoma.